Sign Out
Hypersensitivity to the active substance or to any of the excipients (see Description).
Second and third trimesters of pregnancy (see Precautions and Use in Pregnancy & Lactation).
Biliary obstructive disorders.
Severe hepatic impairment.
The concomitant use of Telmisartan with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR <60
ml/min/1.73 m2) (see Interactions and Pharmacology: Pharmacodynamics under Actions).
In case of rare hereditary conditions that may be incompatible with an excipient of the product (see Description) the use of the product is contraindicated.
Continue with Google